Skip to main content

Innovations that caught my attention recently-#Healthtech

No. 1- Lyme bacteria use the same technique as White Blood Cells to navigate and move in blood vessels


In an interesting case of convergent evolution Lyme bacteria use the same technique as White Blood Cells to navigate and move in blood vessels.To zip through the bloodstream and spread infection throughout the body, the bacteria that cause Lyme disease take a cue from the white blood cells trying to attack them. Both use specialized bonds to stick to the cells lining blood vessels and move along at their own pace, biologist Tara Moriarty and colleagues report September 6 in Cell Reports.

“It’s really an amazing case of convergent evolution,” says Wendy Thomas, a biologist at the University of Washington in Seattle who wasn’t part of the study. “There’s little structural similarity between the molecules involved in these behaviors, and yet their behavior is the same.”


No.2- Wearable Robot for people who lost their hand function


This wearable robot helps disabled patients regain control of their hands. The system consists of a glove that fits between the index finger, middle finger and thumb. Patients who have lost their hand functions due to injuries or nerve-related conditions, such as stroke and muscular dystrophy, now have a chance of restoring their hand movements by using a new lightweight and smart rehabilitation wearable robot.





This is what one customer wrote as feedback after going through the demo-

"To have personally come back from a spinal cord injury - to be able to walk again still blows my mind. changed my view on this power vessel called a body. I love my body- stretchmarks, cellulite and all. It is a wonderful machine. My passion is to continue to educate people on the word function and to truly explore what it means. Much of our society is based on the "look of things" and not the "function" it has damaged the very essence of life for many. This is a wonderful demonstration of dedicated people. Thank you for the service you have provided for many.."

No. 3 Stroke prevention Implant


I have seen many innovations that help predict a stroke and send info to a Doctor remotely to take action and rehabilitate.This new innovation called "Watchman" can be inserted in less than an hour and could save your life. A lot of people might think that it is like striking one thing off their list to worry about. However, good diet and exercise is something still beneficial and should be maintained.
The newly FDA-approved Watchman device is a small implant that reduces the risk of stroke and blood clots.

The blood thinner Warfarin is the standard way doctors try to prevent clots and strokes in patients with irregular rhythms, but the Watchman implant stops blood clots where they start. The majority of clots form in a pouch called the left atrial appendage.

When people have atrial fibrillation in the upper chamber of their heart, known as the atrium, it does not pump, but instead it quivers and that is why the appendage fills with blood. It does not squeeze out the blood and that's how clots are formed.

The Watchman is deployed through a vein in the right leg where the pouch is and it plugs the opening. "Blocking off this pouch is as good as, if not more effective, than taking the blood thinner Warfarin, which is the only other option that many of these patients have," said Dr. Shephal Doshi with the Pacific Heart Institute.

Doshi started the first clinical trial seven years ago. The procedure may not be for everyone with an irregular heartbeat, but it's another option that can be life changing for so many.













Credits:
Hashem Al-Ghaili
Science age
Sciencenature/FB page
Sciencedaily

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki